A citation-based method for searching scientific literature

Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon. Nat Rev Clin Oncol 2018
Times Cited: 359



Catherine M Albert, Jessica L Davis, Noah Federman, Michela Casanova, Theodore W Laetsch. J Clin Oncol 2019
Times Cited: 33




List of shared articles



Times cited

Larotrectinib followed by selitrectinib in a novel DCTN1-NTRK1 fusion undifferentiated pleomorphic sarcoma.
Xue Na Goh, Michaela Su-Fern Seng, Amos Hong Pheng Loh, Achint Gupta, Kenneth Tou En Chang, Prasad Iyer. J Oncol Pharm Pract 2021
1

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Iva Brčić, Theresa Maria Godschachner, Marko Bergovec, Jasminka Igrec, Holger Till, Herwig Lackner, Susanne Scheipl, Karl Kashofer, Thomas Brodowicz, Andreas Leithner,[...]. Mod Pathol 2021
8

What's New in Pediatric Orthopaedic Tumor Surgery.
Amy K Williams, Brooke Crawford, Noah C Federman, Nicholas Bernthal, Alexandre Arkader. J Pediatr Orthop 2021
0

Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.
Esther Conde, Susana Hernandez, Elena Sanchez, Rita Maria Regojo, Carmen Camacho, Marta Alonso, Rebeca Martinez, Fernando Lopez-Rios. Arch Pathol Lab Med 2021
2

[Diagnosis and therapy of tumors with NTRK gene fusion].
Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, Florian Länger, Norbert Graf, Frank Griesinger, Lukas C Heukamp, Michael Hummel, Thomas Klingebiel, Simone Hettmer,[...]. Pathologe 2021
1


Kinase gene fusions: roles and therapeutic value in progressive and refractory papillary thyroid cancer.
Mian Liu, Pei Chen, Hui-Yu Hu, Deng-Jie Ou-Yang, Rooh-Afza Khushbu, Hai-Long Tan, Peng Huang, Shi Chang. J Cancer Res Clin Oncol 2021
0

Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys.
Sijin Duan, Lin Dong, Bingsi Wang, Shujuan Wei, Xiaoyan Gong, Pengfei Yu, Chunmei Li, Yonglin Gao, Liang Ye, Hongbo Wang,[...]. Regul Toxicol Pharmacol 2021
1

Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion.
Roberto Filippi, Ilaria Depetris, Maria Antonietta Satolli. Expert Opin Pharmacother 2021
0

Advances in the Diagnosis and Management of Neonatal Sarcomas.
Tooba Rashid, David H Noyd, Natasha Iranzad, Joseph T Davis, Michael D Deel. Clin Perinatol 2021
0

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.
P Garrido, R Hladun, E de Álava, R Álvarez, F Bautista, F López-Ríos, R Colomer, F Rojo. Clin Transl Oncol 2021
0

NTRK fusions and Trk proteins: what are they and how to test for them.
Lawrence M Weiss, Vincent A Funari. Hum Pathol 2021
0

Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib.
Lily Deland, Simon Keane, Thomas Olsson Bontell, Helene Sjögren, Henrik Fagman, Ingrid Øra, Esther De La Cuesta, Magnus Tisell, Jonas A Nilsson, Katarina Ejeskär,[...]. Cancer Biol Ther 2021
0